Ropharma Bras (RPH) — Capital Reinvestment Ratio

Latest as of March 2023: 0.08x

Ropharma Bras (RPH) has a Capital Reinvestment Ratio of 0.08x as of March 2023, meaning it reinvests 0% of its operating cash flow (RON14.80 Million) in capital expenditures (RON1.20 Million). Check tangible equity quality of Ropharma Bras to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

RON14.80 Million
RON

Capital Expenditures

RON1.20 Million
RON

Data as of

Mar 2023
Most recent filing

Ropharma Bras Capital Reinvestment Ratio (2022–2025)

This chart tracks Ropharma Bras's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see RPH cash flow metrics.

Annual Capital Reinvestment Ratio for Ropharma Bras (2022–2025)

Year-by-year Capital Reinvestment Ratio for Ropharma Bras from 2022 to 2025. See free cash flow generation of Ropharma Bras to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (RON) Capital Expenditures YoY Change
2025 0.43x RON43.16 Million RON18.74 Million ▲ +8.8%
2024 0.40x RON40.49 Million RON16.16 Million ▼ -33.8%
2023 0.60x RON29.94 Million RON18.06 Million ▼ -74.4%
2022 2.35x RON14.65 Million RON34.47 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow